The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sleep Disorder Treatment Drugs-Global Market Insights and Sales Trends 2025
Synopsis
Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.
The global Sleep Disorder Treatment Drugs market size is expected to reach US$ 15720 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Sleep Disorder Treatment Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Research Centers and Others, are propelling Sleep Disorder Treatment Drugs market. Prescription-based Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the OTC Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sleep Disorder Treatment Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sleep Disorder Treatment Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sleep Disorder Treatment Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sleep Disorder Treatment Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sleep Disorder Treatment Drugs covered in this report include Pfizer, Sanofi, Merck, GlaxoSmithKline, Koninklijke Philips, Takeda Pharmaceutical Company, Leva Pharmaceutical Industries, Cardinal Health and Becton Dickson and Company, etc.
The global Sleep Disorder Treatment Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Sanofi
Merck
GlaxoSmithKline
Koninklijke Philips
Takeda Pharmaceutical Company
Leva Pharmaceutical Industries
Cardinal Health
Becton Dickson and Company
Natus Medicalorporated
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
Astellas Pharma
Athenex
Eisai
Evotec
Ferring International Center
Galenica
Heptares Therapeutics (Sosei Group Corporation)
ZYDUS CADILA GROUP
Global Sleep Disorder Treatment Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sleep Disorder Treatment Drugs market, Segment by Type:
Prescription-based Drugs
OTC Drugs
Herbal Drugs
Global Sleep Disorder Treatment Drugs market, by Application
Hospitals
Clinics
Research Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sleep Disorder Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.
The global Sleep Disorder Treatment Drugs market size is expected to reach US$ 15720 million by 2029, growing at a CAGR of 8.4% from 2023 to 2029. The market is mainly driven by the significant applications of Sleep Disorder Treatment Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Research Centers and Others, are propelling Sleep Disorder Treatment Drugs market. Prescription-based Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the OTC Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sleep Disorder Treatment Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sleep Disorder Treatment Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sleep Disorder Treatment Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sleep Disorder Treatment Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sleep Disorder Treatment Drugs covered in this report include Pfizer, Sanofi, Merck, GlaxoSmithKline, Koninklijke Philips, Takeda Pharmaceutical Company, Leva Pharmaceutical Industries, Cardinal Health and Becton Dickson and Company, etc.
The global Sleep Disorder Treatment Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Sanofi
Merck
GlaxoSmithKline
Koninklijke Philips
Takeda Pharmaceutical Company
Leva Pharmaceutical Industries
Cardinal Health
Becton Dickson and Company
Natus Medicalorporated
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
Astellas Pharma
Athenex
Eisai
Evotec
Ferring International Center
Galenica
Heptares Therapeutics (Sosei Group Corporation)
ZYDUS CADILA GROUP
Global Sleep Disorder Treatment Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sleep Disorder Treatment Drugs market, Segment by Type:
Prescription-based Drugs
OTC Drugs
Herbal Drugs
Global Sleep Disorder Treatment Drugs market, by Application
Hospitals
Clinics
Research Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sleep Disorder Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sleep Disorder Treatment Drugs Market Overview
1.1 Sleep Disorder Treatment Drugs Product Overview
1.2 Sleep Disorder Treatment Drugs Market Segment by Type
1.2.1 Prescription-based Drugs
1.2.2 OTC Drugs
1.2.3 Herbal Drugs
1.3 Global Sleep Disorder Treatment Drugs Market Size by Type
1.3.1 Global Sleep Disorder Treatment Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Sleep Disorder Treatment Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sleep Disorder Treatment Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sleep Disorder Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sleep Disorder Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sleep Disorder Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sleep Disorder Treatment Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sleep Disorder Treatment Drugs Sales Breakdown by Type (2018-2023)
2 Global Sleep Disorder Treatment Drugs Market Competition by Company
2.1 Global Top Players by Sleep Disorder Treatment Drugs Sales (2018-2023)
2.2 Global Top Players by Sleep Disorder Treatment Drugs Revenue (2018-2023)
2.3 Global Top Players by Sleep Disorder Treatment Drugs Price (2018-2023)
2.4 Global Top Manufacturers Sleep Disorder Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sleep Disorder Treatment Drugs Market Competitive Situation and Trends
2.5.1 Sleep Disorder Treatment Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sleep Disorder Treatment Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sleep Disorder Treatment Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Sleep Disorder Treatment Drugs Market
2.8 Key Manufacturers Sleep Disorder Treatment Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sleep Disorder Treatment Drugs Status and Outlook by Region
3.1 Global Sleep Disorder Treatment Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sleep Disorder Treatment Drugs Historic Market Size by Region
3.2.1 Global Sleep Disorder Treatment Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Sleep Disorder Treatment Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Sleep Disorder Treatment Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sleep Disorder Treatment Drugs Forecasted Market Size by Region
3.3.1 Global Sleep Disorder Treatment Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Sleep Disorder Treatment Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Sleep Disorder Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sleep Disorder Treatment Drugs by Application
4.1 Sleep Disorder Treatment Drugs Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Research Centers
4.1.4 Others
4.2 Global Sleep Disorder Treatment Drugs Market Size by Application
4.2.1 Global Sleep Disorder Treatment Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Sleep Disorder Treatment Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sleep Disorder Treatment Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sleep Disorder Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sleep Disorder Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sleep Disorder Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sleep Disorder Treatment Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sleep Disorder Treatment Drugs Sales Breakdown by Application (2018-2023)
5 North America Sleep Disorder Treatment Drugs by Country
5.1 North America Sleep Disorder Treatment Drugs Historic Market Size by Country
5.1.1 North America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sleep Disorder Treatment Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Sleep Disorder Treatment Drugs Sales in Value by Country (2018-2023)
5.2 North America Sleep Disorder Treatment Drugs Forecasted Market Size by Country
5.2.1 North America Sleep Disorder Treatment Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Sleep Disorder Treatment Drugs Sales in Value by Country (2024-2029)
6 Europe Sleep Disorder Treatment Drugs by Country
6.1 Europe Sleep Disorder Treatment Drugs Historic Market Size by Country
6.1.1 Europe Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sleep Disorder Treatment Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Sleep Disorder Treatment Drugs Sales in Value by Country (2018-2023)
6.2 Europe Sleep Disorder Treatment Drugs Forecasted Market Size by Country
6.2.1 Europe Sleep Disorder Treatment Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Sleep Disorder Treatment Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Sleep Disorder Treatment Drugs by Region
7.1 Asia-Pacific Sleep Disorder Treatment Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sleep Disorder Treatment Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sleep Disorder Treatment Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sleep Disorder Treatment Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Sleep Disorder Treatment Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sleep Disorder Treatment Drugs Sales in Value by Region (2024-2029)
8 Latin America Sleep Disorder Treatment Drugs by Country
8.1 Latin America Sleep Disorder Treatment Drugs Historic Market Size by Country
8.1.1 Latin America Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sleep Disorder Treatment Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sleep Disorder Treatment Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Sleep Disorder Treatment Drugs Forecasted Market Size by Country
8.2.1 Latin America Sleep Disorder Treatment Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sleep Disorder Treatment Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Sleep Disorder Treatment Drugs by Country
9.1 Middle East and Africa Sleep Disorder Treatment Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Sleep Disorder Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sleep Disorder Treatment Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sleep Disorder Treatment Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sleep Disorder Treatment Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Sleep Disorder Treatment Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sleep Disorder Treatment Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Sleep Disorder Treatment Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Sleep Disorder Treatment Drugs Products Offered
10.2.5 Sanofi Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Sleep Disorder Treatment Drugs Products Offered
10.3.5 Merck Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 Koninklijke Philips
10.5.1 Koninklijke Philips Company Information
10.5.2 Koninklijke Philips Introduction and Business Overview
10.5.3 Koninklijke Philips Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Koninklijke Philips Sleep Disorder Treatment Drugs Products Offered
10.5.5 Koninklijke Philips Recent Development
10.6 Takeda Pharmaceutical Company
10.6.1 Takeda Pharmaceutical Company Company Information
10.6.2 Takeda Pharmaceutical Company Introduction and Business Overview
10.6.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Products Offered
10.6.5 Takeda Pharmaceutical Company Recent Development
10.7 Leva Pharmaceutical Industries
10.7.1 Leva Pharmaceutical Industries Company Information
10.7.2 Leva Pharmaceutical Industries Introduction and Business Overview
10.7.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Products Offered
10.7.5 Leva Pharmaceutical Industries Recent Development
10.8 Cardinal Health
10.8.1 Cardinal Health Company Information
10.8.2 Cardinal Health Introduction and Business Overview
10.8.3 Cardinal Health Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Cardinal Health Sleep Disorder Treatment Drugs Products Offered
10.8.5 Cardinal Health Recent Development
10.9 Becton Dickson and Company
10.9.1 Becton Dickson and Company Company Information
10.9.2 Becton Dickson and Company Introduction and Business Overview
10.9.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Products Offered
10.9.5 Becton Dickson and Company Recent Development
10.10 Natus Medicalorporated
10.10.1 Natus Medicalorporated Company Information
10.10.2 Natus Medicalorporated Introduction and Business Overview
10.10.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Products Offered
10.10.5 Natus Medicalorporated Recent Development
10.11 Mylan N.V.
10.11.1 Mylan N.V. Company Information
10.11.2 Mylan N.V. Introduction and Business Overview
10.11.3 Mylan N.V. Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Mylan N.V. Sleep Disorder Treatment Drugs Products Offered
10.11.5 Mylan N.V. Recent Development
10.12 Teva Pharmaceutical Industries Ltd.
10.12.1 Teva Pharmaceutical Industries Ltd. Company Information
10.12.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
10.12.3 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Products Offered
10.12.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.13 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
10.13.1 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information
10.13.2 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Introduction and Business Overview
10.13.3 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Products Offered
10.13.5 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Development
10.14 Astellas Pharma
10.14.1 Astellas Pharma Company Information
10.14.2 Astellas Pharma Introduction and Business Overview
10.14.3 Astellas Pharma Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Astellas Pharma Sleep Disorder Treatment Drugs Products Offered
10.14.5 Astellas Pharma Recent Development
10.15 Athenex
10.15.1 Athenex Company Information
10.15.2 Athenex Introduction and Business Overview
10.15.3 Athenex Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Athenex Sleep Disorder Treatment Drugs Products Offered
10.15.5 Athenex Recent Development
10.16 Eisai
10.16.1 Eisai Company Information
10.16.2 Eisai Introduction and Business Overview
10.16.3 Eisai Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Eisai Sleep Disorder Treatment Drugs Products Offered
10.16.5 Eisai Recent Development
10.17 Evotec
10.17.1 Evotec Company Information
10.17.2 Evotec Introduction and Business Overview
10.17.3 Evotec Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Evotec Sleep Disorder Treatment Drugs Products Offered
10.17.5 Evotec Recent Development
10.18 Ferring International Center
10.18.1 Ferring International Center Company Information
10.18.2 Ferring International Center Introduction and Business Overview
10.18.3 Ferring International Center Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Ferring International Center Sleep Disorder Treatment Drugs Products Offered
10.18.5 Ferring International Center Recent Development
10.19 Galenica
10.19.1 Galenica Company Information
10.19.2 Galenica Introduction and Business Overview
10.19.3 Galenica Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Galenica Sleep Disorder Treatment Drugs Products Offered
10.19.5 Galenica Recent Development
10.20 Heptares Therapeutics (Sosei Group Corporation)
10.20.1 Heptares Therapeutics (Sosei Group Corporation) Company Information
10.20.2 Heptares Therapeutics (Sosei Group Corporation) Introduction and Business Overview
10.20.3 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Products Offered
10.20.5 Heptares Therapeutics (Sosei Group Corporation) Recent Development
10.21 ZYDUS CADILA GROUP
10.21.1 ZYDUS CADILA GROUP Company Information
10.21.2 ZYDUS CADILA GROUP Introduction and Business Overview
10.21.3 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2018-2023)
10.21.4 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Products Offered
10.21.5 ZYDUS CADILA GROUP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sleep Disorder Treatment Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sleep Disorder Treatment Drugs Industrial Chain Analysis
11.4 Sleep Disorder Treatment Drugs Market Dynamics
11.4.1 Sleep Disorder Treatment Drugs Industry Trends
11.4.2 Sleep Disorder Treatment Drugs Market Drivers
11.4.3 Sleep Disorder Treatment Drugs Market Challenges
11.4.4 Sleep Disorder Treatment Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sleep Disorder Treatment Drugs Distributors
12.3 Sleep Disorder Treatment Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
